Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Apremilast may be a promising long-term treatment for hidradenitis suppurativa.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Systemic agents like cyclosporine, methotrexate, and acitretin help manage psoriasis but have significant side effects.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Matriptase imbalance contributes to cancer development and spread.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

The new nanoparticles could improve melanoma treatment by working better than current options.

Combining platelet-rich plasma and hyaluronic acid effectively reduces pain and improves function in TMJ disorders.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.